Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical, Inc.

Intuitive develops, manufactures, and markets robotic-assisted surgical systems, particularly the da Vinci Surgical System, for minimally invasive surgery.

Intuitive

Intuitive Fosun Hong Kong

Intuitive Israel

Intuitive Fosun

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

Our three-webinar series, Expert Perspectives in Thoracic Oncology, continues with our second episode: Aligning Stakeholders with Data to Improve Patient Pathways.

In this conversation, Dr. Pepper and Moses Cone Thoracic Oncology Team will discuss the importance of engaging with a variety of multidisciplinary colleagues as you build your thoracic oncology program.

July 11th, 2000, isn’t where our story began, but it was a landmark day in our mission to transform surgery—the day that the first da Vinci Surgical System received FDA clearance. 
 
In the years since, surgeons around the world have used five generations of da Vinci systems to help millions of patients. Each generation was an evolution of technology on a journey of progress that never truly ends.
 
Transforming surgery for the benefit of patients, surgeons, and hospitals—that’s Intuitive.

Six years ago, when Intuitive’s Women in da Vinci Surgery Symposium began, there were just six female surgeons in the room. This year? Over 200 surgeons, pulmonologists, and hospital executives gathered in Atlanta, Georgia, to connect, learn, and grow together.

Explore key takeaways from this year’s symposium.

“The best way to grow our people is to grow our business,” says Anuj Mittal, CFO of Intuitive India. Over the past few years, our business has experienced incredible growth, but there's still a massive untapped opportunity in India. We’re looking for talented individuals ready to seize this moment.

At Intuitive India, we’re not just transforming healthcare; we’re building transformative careers. Our vision of enhancing minimally invasive care drives us to innovate, challenge ourselves, and lead in our industry.

Curious to learn more? We sat down with Anuj and fellow leaders Amit Garg and Keith Lavery to discuss the vast opportunities for new team members and the collaborative culture that fuels our growth. Discover insights about our new Global Capability Center and how we’re just scratching the surface of what’s possible.

Ready to be part of something bigger? Read the full story on our blog and see how you can make a real impact with us.
https://lnkd.in/e8RmZn_a
 
#WeAreIntuitive

When Dr. Laila Rashidi was asked how she communicates the benefits of robotic surgery to her patients and colleagues, she said, "Whenever I meet referring physicians or talk to my patients, I always have data to support why I'm doing what I'm doing."

In our new Surgeon Spotlight series, we'll be exploring the world of surgery through the eyes of some of the most skilled and knowledgable physicians in the world. Up first, the inimitable Dr. Laila Rashidi, medical director for colon and rectal surgery at MultiCare Health System.

“The marriage of Case Insights and the ability to review my operative videos—we’re finally at a point where I can put data to the words I’ve been trying to articulate with my fellows for a decade.”
-Mark Soliman, Medical Director of Colorectal Surgery for AdventHealth.

Explore how Case Insights enables surgeons to understand surgical performance like never before.

https://lnkd.in/eEinD5MG

msh id	COM:INTUITIVE
symbol	ISRG
name	Intuitive Surgical, Inc.
homepage url	https://www.intuitive.com
country	US
sector	Healthcare
industry	Medical - Instruments & Supplies
market	STOCKS
employee count	13.68K
crunchbase url	-
linkedin url	-
founders	-

market cap	157.75B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	118
monthly webtraffic growth	-0.93
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.15
growth cost of revenue	0.18
growth depreciation and amortization	0.15
growth ebitda	0.39
growth ebitda ratio	0.21
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.13
growth gross profit ratio	-0.02

COM:INTUITIVE

Intuitive

Last Close

541.82

21/11 21:00

Market Cap

157.75B

Beta: -

Volume Today

1.39M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	5.36B
cost of revenue	5.36B
depreciation and amortization	421.8M
ebitda	2.19B
ebitda ratio	0.31
eps	5.12
eps diluted	5.03
operating expenses	2.96B
operating income	1.77B
operating income ratio	0.25

accounts receivables	-186.3M
capital expenditure	-1.06B
cash at beginning of period	1.6B
cash at end of period	2.77B
inventory	1.22B
working capital ttm	6.23B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-